Eosinophils promote inducible NOS-mediated lung allograft acceptance
- PMID: 29263310
- PMCID: PMC5752306
- DOI: 10.1172/jci.insight.96455
Eosinophils promote inducible NOS-mediated lung allograft acceptance
Abstract
Lungs allografts have worse long-term survival compared with other organ transplants. This is most likely due to their unique immunoregulation that may not respond to traditional immunosuppression. For example, local NO generation by inducible NOS (iNOS) is critical for lung allograft acceptance but associates with rejection of other solid organs. The source of NO in accepting lung allografts remains unknown. Here, we report that, unlike the case for other pulmonary processes in which myeloid cells control NO generation, recipient-derived eosinophils play a critical and nonredundant role in iNOS-mediated lung allograft acceptance. Depletion of eosinophils reduces NO levels to that of recipients with global deletion of iNOS and leads to a costimulatory blockade-resistant form of rejection. Furthermore, NO production by eosinophils depends on Th1 polarization by inflammatory mediators, such as IFN-γ and TNF-α. Neutralization of such mediators abrogates eosinophil suppressive capacity. Our data point to what we believe to be a unique and previously unrecognized role of eosinophil polarization in mediating allograft tolerance and put into perspective the use of high-dose eosinophil-ablating corticosteroids after lung transplantation.
Keywords: Adaptive immunity; Immunology; Respiration; Th1 response; Transplantation.
Conflict of interest statement
Figures
Similar articles
-
Eosinophils downregulate lung alloimmunity by decreasing TCR signal transduction.JCI Insight. 2019 Jun 6;4(11):e128241. doi: 10.1172/jci.insight.128241. eCollection 2019 Jun 6. JCI Insight. 2019. PMID: 31167966 Free PMC article.
-
Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.J Immunol. 2001 Mar 1;166(5):3248-55. doi: 10.4049/jimmunol.166.5.3248. J Immunol. 2001. PMID: 11207279
-
Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.Transplantation. 2016 Dec;100(12):e140-e146. doi: 10.1097/TP.0000000000001480. Transplantation. 2016. PMID: 27861294 Free PMC article.
-
Solving the Conundrum of Eosinophils in Alloimmunity.Transplantation. 2022 Aug 1;106(8):1538-1547. doi: 10.1097/TP.0000000000004030. Epub 2021 Dec 27. Transplantation. 2022. PMID: 34966103 Free PMC article. Review.
-
Deciphering the role of eosinophils in solid organ transplantation.Am J Transplant. 2020 Apr;20(4):924-930. doi: 10.1111/ajt.15660. Epub 2019 Nov 18. Am J Transplant. 2020. PMID: 31647606 Free PMC article. Review.
Cited by
-
PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms.Mol Biol Rep. 2024 Feb 15;51(1):304. doi: 10.1007/s11033-024-09232-y. Mol Biol Rep. 2024. PMID: 38361088 Review.
-
Protective and pathogenic functions of innate lymphoid cells in transplantation.Clin Exp Immunol. 2023 Jul 5;213(1):23-39. doi: 10.1093/cei/uxad050. Clin Exp Immunol. 2023. PMID: 37119279 Review.
-
BAL Fluid Eosinophilia Associates With Chronic Lung Allograft Dysfunction Risk: A Multicenter Study.Chest. 2023 Sep;164(3):670-681. doi: 10.1016/j.chest.2023.03.033. Epub 2023 Mar 30. Chest. 2023. PMID: 37003354
-
Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol.Medicina (Kaunas). 2023 Mar 2;59(3):488. doi: 10.3390/medicina59030488. Medicina (Kaunas). 2023. PMID: 36984489 Free PMC article.
-
The innate immune brakes of the lung.Front Immunol. 2023 Jan 27;14:1111298. doi: 10.3389/fimmu.2023.1111298. eCollection 2023. Front Immunol. 2023. PMID: 36776895 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
